Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Shares Outstanding (Weighted Average) (2019 - 2023)

Historic Shares Outstanding (Weighted Average) for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to $1890.0.

  • ADC Therapeutics' Shares Outstanding (Weighted Average) rose 1117.65% to $1890.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $1890.0, marking a year-over-year increase of 1117.65%. This contributed to the annual value of $80.5 million for FY2022, which is 476.74% up from last year.
  • Per ADC Therapeutics' latest filing, its Shares Outstanding (Weighted Average) stood at $1890.0 for Q3 2023, which was up 1117.65% from $81.5 million recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' Shares Outstanding (Weighted Average) peaked at $81.5 million during Q2 2023, and registered a low of $220.0 during Q1 2022.
  • In the last 4 years, ADC Therapeutics' Shares Outstanding (Weighted Average) had a median value of $1795.0 in 2022 and averaged $17.1 million.
  • Per our database at Business Quant, ADC Therapeutics' Shares Outstanding (Weighted Average) crashed by 6716.42% in 2022 and then skyrocketed by 775905495.24% in 2023.
  • ADC Therapeutics' Shares Outstanding (Weighted Average) (Quarter) stood at $3090.0 in 2020, then surged by 2485397.57% to $76.8 million in 2021, then grew by 4.77% to $80.5 million in 2022, then plummeted by 100.0% to $1890.0 in 2023.
  • Its Shares Outstanding (Weighted Average) was $1890.0 in Q3 2023, compared to $81.5 million in Q2 2023 and $740.0 in Q1 2023.